Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
US10610506B2 · kind B2 · utility
4Cited by
29References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 10, 2017 |
| Grant date | Apr 7, 2020 |
| Priority date | — |
| Expiry date | Feb 10, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to use of ornithine in the manufacture of a medicament for use in combination with at least one of phenylacetate and phenylbutyrate for preventing or treating liver decompensation or hepatic encephalopathy. The invention also relates to use of at least one of phenylacetate and phenylbutyrate in the manufacture of a medicament for use in combination with ornithine for preventing or treating liver decompensation or hepatic encephalopathy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.